Notice NOT-DK-24-024 from the NIH Guide for Grants and Contracts

Southern Research: Director of Bioinformatics General Summary Southern Research (SR) is at a pivotal moment in its 82-year history. At the start of 2022, SR launched... Birmingham, Alabama

Notice NOT-CA-24-072 from the NIH Guide for Grants and Contracts

Notice NOT-DA-26-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-250 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to support the creation of standards and related efforts that will allow researchers to easily access data from personal tracking devices. The awardees will be expected to partner with device manufacturers as well as the researcher community if the effort is going to be successful. It is expected that the awardees will create standards for personal tracking device data that serve the same purpose as the DICOM or Neuroimaging Informatics Technology Initiative (NIfTI) formats and standards do for medical image files.

Competitive: CK Group: CK Group are working in partnership with Nxera Pharma UK Limited (formerly Sosei Heptares) to recruit an Associate Director, Quantitative Systems Biology, Translational Medicine based... Cambridge

InVitro Cell Research, LLC: We're hiring Bioinformatics Scientists with strong backgrounds in database development, management and analysis as they relate to human health and... Leonia, New Jersey

$150,000 – $175,000, depending on experience.: Simons Foundation: SPARK, launched by the Simons Foundation in 2016, is the largest study of autism ever undertaken. New York City, New York (US)

Funding Opportunity PAS-24-242 from the NIH Guide for Grants and Contracts. Data science is an important cross-cutting research approach in the 2022 - 2026 NIDA Strategic Plan and increasing the capacity of experts in addiction related data science is critical. The purpose of this Notice is to facilitate the entry of investigators to the area of addiction-related data science, including newly independent data scientists or established investigators seeking to incorporate novel and cutting-edge data science methodologies into their research programs for the first time. Through this opportunity, investigators will propose to apply emerging data science methods to answer critical questions requiring advanced data analytic strategies. Projects should be small in scale and answer specific research questions or provide preliminary data for a larger scale project. Applicants are encouraged to use existing datasets, follow FAIR principles, and, when applicable, attend to ethical concerns in the conduct of research involving human subjects. Ultimately, the aim is to expedite the development of robust research programs focused on the convergence of innovative data science techniques and addiction research, with initial projects serving as precursors for subsequent, more expansive research projects.

Notice NOT-CA-25-071 from the NIH Guide for Grants and Contracts

Notice NOT-MD-24-021 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-134 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-135 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-136 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-137 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-138 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-139 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-25-011 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions to prevent and or treat the cognitive, behavioral,and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) and 2) stimulate studies to enhance trial design and methods.

Funding Opportunity RFA-AG-25-010 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications to develop and implement multi-site Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.

Notice NOT-OD-24-148 from the NIH Guide for Grants and Contracts